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Cellular/Molecular
The Antiaging Protein Klotho Enhances Oligodendrocyte
Maturation andMyelination of the CNS
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We have previously shown that myelin abnormalities characterize the normal aging process of the brain and that an age-associated
reduction in Klotho is conserved across species. Predominantly generated in brain and kidney, Klotho overexpression extends life span,
whereas loss of Klotho accelerates the development of aging-like phenotypes. Although the function of Klotho in brain is unknown, loss
of Klotho expression leads to cognitive deficits. We found significant effects of Klotho on oligodendrocyte functions, including induced
maturation of rat primary oligodendrocytic progenitor cells (OPCs) in vitro and myelination. Phosphoprotein analysis indicated that
Klotho’s downstream effects involve Akt and ERK signal pathways. Klotho increased OPC maturation, and inhibition of Akt or ERK
function blocked this effect onOPCs. In vivo studies of Klotho knock-outmice and control littermates revealed that knock-outmice have
a significant reduction in major myelin protein and gene expression. By immunohistochemistry, the number of total and mature
oligodendrocytes was significantly lower in Klotho knock-outmice. Strikingly, at the ultrastructural level, Klotho knock-outmice exhib-
ited significantly impaired myelination of the optic nerve and corpus callosum. These mice also displayed severe abnormalities at the
nodesofRanvier. Todecipher themechanismsbywhichKlothoaffects oligodendrocytes,weused luciferasepathway reporters to identify
the transcription factors involved. Together, these studies provide novel evidence forKlotho as a key player inmyelin biology, whichmay
thus be a useful therapeutic target in efforts to protect brain myelin against age-dependent changes and promote repair in multiple
sclerosis.
Introduction
Klotho is an antiaging protein named after the mythical Greek
goddess who “spins the thread of life” (Kuro-o et al., 1997).
Klotho knock-out mice exhibit many changes that also frequently
occur during human aging, including arteriosclerosis, osteopo-
rosis, and cognitive decline. The mice develop normally but die
prematurely, with an average life span of 61 d (Kuro-o et al.,
1997), whereas mice overexpressing Klotho live 30% longer than
wild-type mice (Kurosu et al., 2005). In early adulthood, Klotho
knock-out mice show memory retention deficits (Nagai et al.,
2003), a reduction in synapses in the hippocampus (Li et al.,
2004), perturbations in axonal transport, and a neurodegenera-
tive phenotype in the hippocampus (Shiozaki et al., 2008). Inter-
estingly, humans carrying the Klotho-VS polymorphism exhibit
reduced cognitive abilities (Nagai et al., 2003; Deary et al., 2005),
as well as reduced life span (Nagai et al., 2000; Arking et al., 2003;
Arking et al., 2005). The basis of cognitive deficits in Klotho
knock-out mice or in humans with Klotho-VS polymorphism is
not known, and a more thorough assessment of neuropathology
is needed.
Klotho is highly expressed in the choroid plexus and neurons,
especially in the hippocampus, as well as in the kidney and repro-
ductive organs (Kuro-o et al., 1997), but its function in the brain
is not clear. Klotho is a type I transmembrane protein cleaved by
ADAM10 and 17 from the cell membrane (Chen et al., 2007;
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Bloch et al., 2009) and is detectable in serum and CSF (Imura et
al., 2004). Klotho functions include regulation of FGF23 signal-
ing, suppression of the insulin/IGF1 and Wnt signaling pathways,
and regulation of calcium and phosphate homeostasis (Kuro-o,
2010). In contrast to other organ systems, none of the down-
stream effects of Klotho has been studied for the CNS and little is
known regarding the downstream signal transduction machinery
required for Klotho’s CNS effects. Considering the distribution
of Klotho expression and processing within the CNS and the
effects on cognition cited above, Klotho is positioned to influence
a variety of CNS structures and functions in development and
aging.
As part of our studies of age-associated cognitive decline in the
rhesus monkey, we discovered using microarray analysis that
Klotho expression was decreased in the aged corpus callosum
(Duce et al., 2008), probably because of the hypermethylation of
its promoter (King et al., 2012). This is of interest as damage to
myelin is ubiquitous in aging monkey brain (Kohama et al., 2011)
at biochemical (Sloane et al., 2003), ultrastructural (Bowley et al.,
2010), and macroscopic levels (Makris et al., 2007; Wisco et al.,
2008), and these abnormalities are often associated with cogni-
tive decline (Hinman and Abraham, 2007; Peters, 2009). To de-
termine whether there is a connection between age-related
alterations in Klotho expression (Duce et al., 2008) and CNS
dysmyelination (Sloane et al., 2003; Hinman and Abraham,
2007), and to understand the functions of Klotho in the brain,
we assessed how Klotho influences oligodendrocyte function
and developmental myelination and describe here the impor-
tant and novel role Klotho plays in oligodendrocyte biology
and myelination.
Materials andMethods
Materials. The recombinant mouse Klotho protein containing the extra-
cellular domain of mouse Klotho (Ala 35-Lys 982) was from R&D Sys-
tems. Akt inhibitor LY294002 and ERK inhibitor UO126 were from Cell
Signaling Technology. Growth factors for oligodendrocytes were from
Peprotech. All other chemicals were from Sigma-Aldrich.
Animal tissue and protein sample preparation. Klotho knock-out
(Kuro-o et al., 1997) and control mice were perfused with 0.1 M PBS, pH
7.4, at 4°C and hemibrains homogenized in 5 (v/w) ice-cold RIPA
buffer with protease and phosphatase inhibitor cocktails (Roche) (King
et al., 2012). Samples were then centrifuged at 16,000 g for 15 min, and
the supernatant was collected for SDS-PAGE and Western blot analysis.
Oligodendrocyte progenitor cell (OPC) cultures. OPCs were isolated
from female Sprague Dawley postnatal day 2 rat pups as described pre-
viously (Mi et al., 2005; Sloane and Vartanian, 2007). Cultures were
maintained in high-glucose DMEM OPC culture medium (4 mM
L-glutamine, 1 mM sodium pyruvate, 0.1% BSA, 50 g/ml insulin, 30 nM
sodium selenite, 10 nM D-biotin, and 10 nM hydrocortisone) containing
bFGF/PDGF (10 ng/ml) for 1–3 d and replaced with either DMEM me-
dium with CNTF (10 ng/ml), T3 (15 nM), and NT3 (10 ng/ml), or
DMEM with CNTF and NT3 alone, with or without recombinant mouse
Klotho at a concentration of 0.4 g/ml at 37°C for 3– 8 d, as indicated in
the figures. Half of the medium bathing the cells was replaced with fresh
medium with or without Klotho every other day. The same concentra-
tion of Klotho was used in all experiments. The cell lysates were collected
in RIPA buffer as described previously, and protein samples were ana-
lyzed by SDS-PAGE and Western blotting.
Western blotting. Protein concentrations were measured using the Mi-
cro BCA Protein Assay Reagent Kit (Pierce) according to the manufac-
turer’s protocol. For SDS-PAGE, cell lysates containing the same amount
of total protein were boiled for 5 min and loaded on 4 –20% precast
Tris-Glycine gels (Bio-Rad). Proteins were transferred to nitrocellulose
membranes (Millipore). All antibodies were diluted in TBST (50 mM
Tris, pH 8.0, 150 mM NaCl, and 0.1% (v/v) Tween 20) containing 5%
(w/v) nonfat dry milk. Secondary antibodies were horseradish peroxidase-
conjugated goat anti-mouse, anti-rat, or anti-rabbit (1:5000, Kirkegaard
& Perry Laboratories). Enhanced chemiluminescence was detected using
Immobilon Western Chemiluminescent Substrate (Millipore). Autora-
diography was done using Kodak Scientific Imaging Film X-OMAT AR
(Eastman Kodak).
The primary antibodies used were as follows: anti-myelin basic protein
(MBP) mouse monoclonal antibody (1:1000, Covance), anti-myelin-
associated glycoprotein (MAG) mouse monoclonal antibody (clone
B11F7, 1:1000), anti-2, 3cyclic nucleotide-3-phosphodiesterase mouse
monoclonal antibody (1:1000, Sigma), anti-FGF receptor substrate
(FRS) Y196 (1:1000, Cell Signaling Technology), anti-OSP rabbit poly-
clonal antibody (1:1000, Abcam), anti-proteolipid protein (PLP) mouse
monoclonal antibody (1:1000, Millipore), anti-PCNA clone PC10 (1:
1000, Millipore), and anti--tubulin monoclonal antibody (1:1000, In-
vitrogen). The antibodies in the Akt and ERK pathways were from
phospho Akt and ERK pathway kit (Cell Signaling Technology) and were
used according to the manufacturer’s protocol.
qRT-PCR. Total RNA was isolated using QIAGENs RNeasy kit (QIA-
GEN). A reverse transcription was performed with 2 g of total RNA
from each sample. Primers for selected mouse myelin-related genes (see
Table 1) and corresponding rat oligodendrocyte maturation-enriched
genes as published previously (Cahoy et al., 2008) were designed by
RealTimePrimers. Controls included  actin, -2 microglobulin, phos-
phoglycerate kinase 1, hypoxanthine phosphoribosyltransferase 1, and
GAPDH. The qRT-PCR experiments were performed with iQ SYBR
Green Supermix (Bio-Rad) with detection on a Bio-Rad C1000 Thermal
Cycler. The whole cDNA from 2g of total RNA was used for one 96-well
plate. Triplicates of 20 l reactions containing primer and cDNA tem-
plate were used for quantitation. A PCR was carried out as follows: 1 cycle
of 95°C for 3 min followed by 40 cycles of 95°C for 10 s, 55°C for 20 s, and
72°C for 30 s. This was followed by a dissociation curve beginning at 55°C
and increasing by 0.2°C every 3 s, with SYBR Green fluorescence mea-
sured at every interval. Relative quantitation of the difference between
the control and Klotho-treated samples was done using RT 2 Profiler PCR
Array Data Analysis Program (QIAGEN). Genes were tested for statisti-
cal significance (p 0.05), relative to the control, by Student’s t test.
Luciferase assay. Paired homeodomain protein 3 (Pax3) reporter plas-
mid (pluc-TKCD-19) was kindly provided by Dr. Frank Rauscher III
(Wistar Institute, Philadelphia, Pennsylvania). Signal Transduction 45
pathway Reporter Array (see Tables 2 and 3) was from SABiosciences
(QIAGEN). OPCs were plated into 96-well plates at a density of 0.65
10 6 cells/plate in OPC culture medium containing bFGF/PDGF for 3 d
before transfection. A total of 200 ng of Luciferase reporter or control
empty-vector DNA (with 5 ng Renilla luciferase) was transfected into
Table 1. Myelin-related genes used in qPCR analysis comparing gene expression of
Klotho/ and Klotho/mice brain samples at 8 weeks of age
Symbol Description Fold changea p
Aspa Aspartoacylase 1.99 0.0374b
CNP 2,3-cyclic nucleotide 3 phosphodiesterase 2.26b 0.0419b
EDG2 Lysophosphatidic acid receptor 1 2.18b 0.0271b
Enpp2 Ectonucleotide pyrophosphatase/phosphodiesterase 2 1.73 0.0345b
Erbb3 v-erb-b2 erythroblastic leukemia viral oncogene
homolog 3
1.92 0.0196b
Klk6 Kallikrein-related peptidase 6 7.35b 0.0237b
MAG Myelin-associated glycoprotein 3.97b 0.0266b
MBP Myelin basic protein 4.68b 0.0189b
MAL Myelin and lymphocyte protein, T-cell differentiation
protein
2.09b 0.0479b
MOBP Myelin-associated oligodendrocytic basic protein 3.15b 0.0132b
MOG Myelin oligodendrocyte glycoprotein 2.88b 0.0045b
Olig2 Oligodendrocyte transcription factor 2 1.54 0.1581
Pllp Plasma membrane proteolipid 2.26b 0.0051b
Plp1 Proteolipid protein (myelin) 1 2.30b 0.0097b
Pmp22 Peripheral myelin protein 22 3.94b 0.0715
aFold change represents Klotho/ compared with Klotho/ as control. N 4 for each group.
bp 0.05 and fold change2.
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cells using Lipofectamine 2000 (Invitrogen), and cells were treated with
or without recombinant mouse Klotho in OPC culture medium as de-
scribed above. Twenty-four hours after transfection, cells were washed
once with PBS and assayed for luciferase activity using the Dual-
luciferase system (Promega) as described previously (Oh et al., 2010).
Immunofluorescence. Cells were fixed in 4% paraformaldehyde in PBS
at room temperature, rinsed with PBS, and treated for 1 h with blocking
solution (PBS supplemented with 0.1% Triton X-100 and 1% BSA). Cells
were incubated overnight at 4°C with the primary antibody diluted in
blocking solution. Cells were stained with antibodies to Olig2 (1:10,000;
Millipore), CC-1 (1:200; Millipore), or O1 (1:2; ATCC). Subsequently,
cells were rinsed and incubated with the relevant secondary antibodies
(Cy3 or Alexa-488; Jackson ImmunoResearch Laboratories) for 1 h at
room temperature. Immunofluorescence images were obtained by a
Nikon Eclipse 660 microscope and a SPOT-cooled CCD digital camera
(Diagnostic Instruments). For every condition, we identified the matu-
ration state of each OL for the 30 – 60 cells within a given field for all
fields acquired (N  450 –900 cells/condition) from 3 independent ex-
periments. We quantified numbers of mature OLs (O1 or CC1) and
total OL-lineage cells (Olig2) and determined percentage mature OLs
of total OL lineage cells (O1/Olig2 or CC1/Olig2) (because
Olig2 labels OPCs as well as OLs).
Cell number determination, cell viability assay, and LDH release. Cell
number was determined colorimetrically by crystal violet staining as de-
scribed previously (Zeldich et al., 2007). Cells were plated at 50,000 cells/
well in 24-well plates in triplicates and allowed to attach and spread in
OPC culture medium containing bFGF/PDGF for 1–3 d and then re-
placed with medium containing CNTF and NT3, with or without Klotho
for the indicated time periods. At the end of each time interval, the cells
were washed with PBS, fixed in 70% ethanol, and kept at 4°C until the
staining with 1% crystal violet. Unincorporated stain was removed by
washing, cells were air-dried, and the dye was extracted with 70%
ethanol and optical density (absorbance 550 nm and baseline refer-
ence absorbance 750 nm) was measured by Microplate Reader (Glo-
max Multi Detection System, Promega). The data analysis was done
by subtracting the baseline readings (750 nm) from the absorbance
readings (560 nm).
For cell viability assay, cells were plated in 96-well plates in six repeats
and allowed to attach and spread in OPC culture medium containing
bFGF/PDGF for 3 d and then replaced with medium containing CNTF
and NT3, with or without Klotho for the indicated time periods. At the
end of each time interval, cell number was assessed using CellTiter-Glo
Luminescent Cell Viability Assay (Promega) according to the manufac-
turer’s instructions. This assay signals the presence of metabolically ac-
tive cells. Briefly, 100 l of CellTiter Glo Reagent was added to the equal
volume of cell culture medium present in each cell culture well. The
contents were mixed for 2 min and after stabilization of the signal at
room temperature for 10 min, the luminescence was recorded on a Mi-
croplate Reader (Glomax Multi Detection System, Promega). Cell death
was assessed by using the CytoTox 96 nonradioactive cytotoxicity assay
(Promega), which measures the LDH release into the medium.
Immunohistochemistry and cell counting in wild-type and Klotho knock-
out mice. Five-week-old Klotho/ and Klotho/ mice were perfused
through the heart with 0.1 M PBS (4°C, pH 7.4). The brains were re-
moved, and one hemisphere was immersion fixed in 4% paraformalde-
hyde overnight while the other was left unfixed and flash frozen with
pulverized dry ice and stored at 80°C. The fixed hemisphere was re-
moved from fixative the next day and cryoprotected in successive solu-
tions of first 10%, then 20% glycerol in PBS with 2% DMSO (Rosene et
al., 1986). The frozen hemibrains were cut in the coronal plane into
30-m-thick sections with a sliding microtome. The sections were di-
vided into six interrupted series and stored at 4°C in 0.1 M PBS with 1%
sodium azide as a preservative until they were processed.
For Olig2, CC-1, and GST-Pi immunohistochemistry, one series from
each subject was selected and all sections were processed together in a
single batch at the same time in the same reagents to eliminate any
procedural variance. All steps were performed at room temperature un-
less otherwise indicated. Free-floating sections were washed, quenched
with 3% hydrogen peroxide, and then blocked with 10% normal goat
serum in PBS with 0.4% Triton X-100 for 1 h. Next, sections were incu-
bated in a stock solution (1% normal goat serum, 0.2% Triton X-100 in
0.05 M PBS) containing rabbit polyclonal anti-Olig2 antibody (Millipore
ab9610, 1:10,000), mouse mAb against CC-1 (Millipore OP-80, 1:40) or
anti-GST Pi (Abcam, 1:500) for 48 h at 4°C. Sections were then washed in
Table 2. Signal transduction 45-pathway reporter array
Reporter Pathway Transcription factor
AARE Amino acid deprivation response ATF4/ATF3/ATF2
AR Androgen receptor Androgen receptor
ARE Antioxidant response Nrf2 and Nrf1
ATF6 ATF6 ATF6
C/EBP C/EBP C/EBP
CRE cAMP/PKA CREB
E2F Cell cycle E2F/DP1
p53 p53/DNA damage p53
EGR1 EGR1 EGR1
ERSE Endoplasmic reticulum stress CBF/NF-Y/YY1
ERE Estrogen receptor Estrogen receptor
GATA GATA GATA
GRE Glucocorticoid receptor Glucocorticoid receptor
HSR Heat shock response HSF
MTF1 Heavy metal stress MTF1
GLI Hedgehog GLI
HNF4 Hepatocyte nuclear factor 4 HNF4
HIF Hypoxia HIF-1
IRF1 Interferon regulation IRF1
ISRE Type I interferon STAT1/STAT2
GAS Interferon STAT1/STAT1
KLF4 KLF4 KLF4
LXR Liver X receptor LXRa
SRE MAPK/ERK Elk-1/SRF
AP1 MAPK/JNK AP-1
MEF2 MEF2 MEF2
Myc c-myc Myc/Max
Nanog Nanog Nanog
RBP-Jk Notch RBP-Jk
NFB NFB NFB
Oct4 Oct4 Oct4
Pax6 Pax6 Pax6
FOXO PI3K/AKT FOXO
NFAT PKC/Ca 2 NFAT
PPAR PPAR PPAR
PR Progesterone receptor Progesterone receptor
RARE Retinoic acid receptor Retinoic acid receptor
RXR Retinoid X receptor Retinoid X receptor
Sox2 Sox2 Sox2
SP1 SP1 SP1
STAT3 STAT3 STAT3
SMAD TGF SMAD2/SMAD3/SMAD4
VDR Vitamin D receptor Vitamin D receptor
TCF/LEF Wnt TCF/LEF
XRE Xenobiotic AhR
Table 3. Transcriptional regulatory element sequence information of the luciferase
reporters involved in Klotho-dependent responses in OPCs
Reporter Pathway Transcriptional regulatory element sequence
AP1 MAPK/JNK TGAGTCAG
ARE Antioxidant response AACATTGCATCATCCCCGC
C/EBP C/EBP ATTGCGCAAT
LXR Liver X receptor TGAATGACCAGCAGTAACCTCAGC
NFB NFB GGGACTTTCC
PR Progesterone receptor GGGACATGGTGTTCT
SRE MAPK/ERK GGATGTCCATATTAGGA
STAT3 STAT3 GTCGACATTTCCCGTAAATCGTCGA
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stock solution and treated with biotinylated
goat anti-rabbit or anti-mouse secondary anti-
body (1:600, BA5000, Vector Laboratories) for
1 h. After washing, sections were incubated
with an avidin-biotinylated horseradish perox-
idase enzyme complex (PK6100, Vectastain
Elite ABC kit, Vector Laboratories) for 1 h,
rinsed in KPBS, then sodium acetate buffer
(0.175 M), and processed with a solution of
nickel sulfate hexahydrate (0.095 M), 3,3 di-
aminobenzidine tetrahydrochloride (DAB)
(0.55 mM), and hydrogen peroxide (0.0025%)
in 0.175 M sodium acetate buffer for 15 min.
The immunostained sections were mounted
on gelatin-coated slides and air-dried. Then
sections were defatted in chloroform:ethanol
(1:1), rehydrated, counterstained with Neu-
tral Red (1%), dehydrated in a series of etha-
nols, cleared in xylenes, and coverslipped
with Permount (Fisher Scientific).
To quantify Olig2 and GST-Pi cells, the
fractionator method was used to obtain a pop-
ulation estimate within the fimbria. The fim-
bria was chosen because it is an easily defined and circumscribed bundle
of white matter. The fimbria was outlined in six 30 m sections spaced
180 m apart, starting rostrally at the level of the anterior end of the
habenula and spanning 1.08 mm caudally using StereoInvestigator
system (Version 9.14.3, MBF Bioscience) and a 4Nikon Plan objective
on a Nikon Eclipse E600 microscope. Cell counts were made with a 20
Nikon Plan Fluor objective. A 120m 120m grid was overlaid on the
region of interest, and Olig2 cells were counted within 40m 40m
counting frames placed at the grid intersections that fell within the out-
line of the fimbria. The criterion for counting cells was the appearance of
the black Ni-DAB immunoproduct in the nucleus. In an adjacent series
of six 30-m-thick tissue sections, GST-Pi cells within the fimbria were
quantified. The fimbria was outlined with a 4 objective as described
above. A 120 m  120 m sampling grid was superimposed over the
region of interest, and GST-Pi cells were counted within a 40m 40
m counting frame and 5m disector using a 60Nikon Plan Fluor oil
objective. A guard volume of 1 m above the disector box was used and
2– 4 m below, depending on the thickness of the tissue section (8 –10
m total). GST-Pi cells had brown DAB immunoproduct in the cyto-
plasm and nucleolus, yet the nucleus was unstained.
Nodal and paranodal immunofluorescence. Free-floating 30 m sec-
tions were stained for nodes and paranodes with rabbit anti--IV spec-
trin (1:400) or rabbit anti-NaV1.6 (1:200) (gifts from M. Rasband, Baylor
College of Medicine) (Rasband et al., 2003; Ogawa et al., 2006), and
mouse anti-caspr antibodies (1:500), using the following protocol with
all steps performed at room temperature unless otherwise stated. The
monoclonal antibody mouse anti-caspr (clone K65/35) was developed by
and obtained from the UC Davis/National Institutes of Health Neuro-
mab Facility. Sections were washed in PBS, transferred to prewarmed 10
mM sodium citrate, pH 8.5, and incubated at 80°C for 30 min for antigen
retrieval. After cooling to room temperature, sections were washed 3
times in PBS, then blocked and permeabilized in PBS with 0.3% TX-100
(Sigma) and 10% normal donkey serum (Jackson ImmunoResearch Lab-
oratories) for 30 min. Sections were then placed directly in MOM Block
(Vector Laboratories) diluted in PBS for 1 h, washed 3 times in PBS, and
then incubated overnight in primary antibody cocktails. The next day,
after 3 washes in PBS, sections were incubated in donkey anti-mouse Cy2
(Jackson ImmunoResearch Laboratories; 1:300) and donkey anti-rabbit
DyLight 549 (Jackson ImmunoResearch Laboratories; 1:300) for 1 h.
Sections were then mounted on gelatin subbed slides, air dried, and
dehydrated with 70 –100% EtOH and xylene and coverslipped with DPX
mounting medium.
Image acquisition was performed on a Nikon Eclipse Ti C2 laser
scanning confocal microscope. Two-micron optical sections at 100
optical objective with 2 digital zoom were obtained from five different
immunolabeled sections from each of two wild-type and two Klotho-null
mice. The imaged white matter included corpus callosum overlying stria-
tum to that overlying hippocampus. Maximum intensity projections
were obtained and images were postprocessed in NIS Elements software
(Nikon). Nodal and paranodal segments were measured using the two-
point length measurement tool. For measurement, only complete para-
nodal pairs (both paranodes and an immunolabeled node) were selected
for measurement. A total of 30 paranodes per section (150 per animal)
were measured, and a total of 10 nodes per section (50 per animal) were
measured. Statistical significance was determined using a Student’s t test
assuming one tail and equal variance. For presentation, images were
further postprocessed and cropped in Photoshop CS5 (Adobe).
Electron microscopy. Thirty-five-day-old Klotho/, Klotho/, and
Klotho/ mice, and 25-d-old Klotho/ mice were perfused transcar-
dially with 1% paraformaldehyde and 2.5% glutaraldehyde fixative in 0.1
M cacodylate buffer, pH 7.2–7.4. Optic nerve, corpus callosum, and cer-
vical spinal cord were postfixed with 1% osmium oxide, dehydrated in
alcohol series and propylene oxide before embedding in Epon. One-
micrometer-thick sections were cut and stained with toluidine blue. Thin
sections were contrasted with uranyl acetate and lead citrate and imaged
with a JEOL 1200EX electron microscope.
Gene set enrichment analysis. Gene set enrichment analysis was per-
formed according to Subramanian et al. (2005) with 1186 chemical and
genetic perturbation gene sets. Klotho/ mice versus Wild-type/
mice gene expression profiles were ranked based on p value. The ranked
gene list was used as input for the chemical and genetic perturbation gene
sets. The significant gene sets were selected based on the normalized
enrichment score and false discovery rate, accordingly.
Results
Klotho effects on primary oligodendrocytes in vitro
Klotho has been reported to affect intracellular signaling through
Akt and ERK1/2 pathways in HEK293 and breast cancer cells
(Kurosu et al., 2006; Wolf et al., 2008). We therefore assessed
whether Klotho induces ERK1/2 and Akt protein phosphoryla-
tion from 0 – 60 min in OPCs isolated from rat brain. Western
blot results indicated that proteins in the ERK1/2 and Akt path-
way, including PTEN (Ser380), Akt (Ser473), and GSK-3
(Ser9), were phosphorylated upon Klotho treatment (Fig. 1).
We found two waves of GSK3 phosphorylation in OPCs
upon Klotho treatment, with a first peak at 10 min and a
second at 45 min (Fig. 1). These results suggest that the Akt
and ERK/12 pathways are both involved in Klotho-induced
signaling in rat primary OPCs. We also examined phosphory-
lation of FGF receptor substrate 2 (FRS2) because Klotho may
function by modulating FGF signal transduction pathways
Figure 1. Phosphorylation kinetic analysis of Klotho-treated OPCs. A, OPCs were treated with Klotho for the times indicated,
and the cell lysates were analyzed by Western blotting for protein phosphorylation of the proteins indicated. B, Kinetics of the
signal intensity based on band densitometry as in A. Results represent the average of two independent experiments. Phosphory-
lated ERK1/2 and Akt are normalized to total ERK1/2 and Akt, respectively. All other phosphorylated proteins are normalized to
GAPDH internal control.
1930 • J. Neurosci., January 30, 2013 • 33(5):1927–1939 Chen et al. • Klotho Affects Myelination
(Kurosu et al., 2006; Urakawa et al., 2006). Western blot re-
sults indicated that FRS2 was phosphorylated at Y196 upon
Klotho treatment (Fig. 1), suggesting that the FGF signaling
pathways may be involved in Klotho-induced signaling in rat
OPCs. However, it is also possible that Klotho affects FRS2
phosphorylation via Klotho’s interaction with the TrkA recep-
tor (Meakin et al., 1999).
To examine the effects of Klotho on the OPC phenotype, oli-
godendrocyte maturation was assessed by immunohistochemis-
try for mature oligodendrocytes (O1), and pan-oligodendrocytes
(Olig2) after Klotho treatment. The OPCs were allowed to attach
and spread in OPC culture medium containing bFGF/PDGF for
3 d and then replaced with medium containing CNTF and NT3
with or without Klotho. After 3 and 6 d of Klotho treatment, we
found that Klotho increased the percentage of mature primary
oligodendrocytes (% O1/Olig2; Fig. 2A,B). Similar results were
obtained using another marker of mature oligodendrocytes,
CC-1 (Fig. 2C). Klotho enhances OPC maturation in medium
containing CNTF and T3, or in medium containing CNTF, T3,
and NT3 (Fig. 2D). Because both Akt and ERK1/2 phosphoryla-
tion occurred rapidly after exposure to Klotho, we asked whether
Akt and ERK1/2 function is required for Klotho’s effects on OPC
maturation. OPCs were treated with Klotho in the presence or
absence of Akt and ERK inhibitors (LY294002 (LY) for Akt inhi-
Figure 2. Klotho effects in vitro on primary OPCs. A–D, Klotho enhances oligodendrocyte maturation. Rat OPCs were treated with Klotho ( Klotho) or with PBS (Control) for 3 d, and then
immunostained for the mature oligodendrocyte marker O1 (green), and pan-oligodendrocyte marker Olig2 (red). A, A typical O1 staining of a differentiated oligodendrocyte. B, Statistical analysis
ofO1andOlig2 stainingofOPCs at 3and6d treatmentwithKlothoorPBS. *Statistical significance ( p0.005, t test). Error bars indicate SD.C, ImmunostainingofOPCswithantibodies to themature
oligodendrocytemarker CC-1 (green) and pan-oligodendrocytemarker Olig2 (red). Cell nuclei were stainedwith DAPI (blue).White arrows in themerged image indicate nonoligodendrocytic cells,
and yellow arrows indicate undifferentiated oligodendrocytes. D, Statistical analysis of the ratio of CC-1 to Olig2 staining of OPCs at 3, 6, and 8 d of treatment with Klotho or PBS in medium 1 (OPC
culturemediumcontaining CNTF and T3) ormedium2 (OPC culturemediumcontaining CNTF, T3, andNT3). *Statistical significance ( p0.005, t test). Error bars indicate SD.E, Klotho enhancesOPC
maturation via ERK and Akt signaling. Rat OPCs were treated with 0.5M LY294002 (LY) (for Akt inhibition) or 1M UO126 (UO) (for ERK inhibition) for 30min before Klotho (KL) was added. OPCs
were treated for 3 d and then immunostained as inD. Statistical analysis of the results is plotted. F, Klotho enhancesmajormyelin proteins expression in rat OPCs. OPCswere treatedwith orwithout
Klotho for 6 d in culturemedium containing CNTF and T3 and blotted with the antibodies indicated with tubulin as loading control.G, The relative signal intensity based on band densitometry was
plotted as relative percentage to control without Klotho treatment. Results represent the average of three to five independent experiments. All proteins are normalized to tubulin internal control.
*Statistical significance ( p 0.005, t test). Error bars indicate SD.H, Klotho does not affect OPC cell viability. CellTiterGlo assay was used to assess Klotho’s effect on OPC cell viability after 1–4 d of
Klotho treatment. Error bars indicate SD. Results represent the average of six independent experiments. I, Klotho does not affect OPC cell proliferation. Cell numbers were assayed by crystal violet
staining at day 2 and day 4 after Klotho treatment. Error bars indicate SD. Results represent the average of three independent experiments.
Chen et al. • Klotho Affects Myelination J. Neurosci., January 30, 2013 • 33(5):1927–1939 • 1931
bition or UO126 (UO) for ERK inhibi-
tion). Inhibition of ERK function
reduced, while Akt functional inhibition
completely abolished, the effects of
Klotho on OPC maturation (Fig. 2E), sug-
gesting that Klotho enhances OPC matu-
ration primarily via signaling requiring
Akt but also, to a more limited degree,
through ERK1/2. Western blot analysis of
Klotho-treated OPCs revealed that
Klotho enhanced the expression of the
major myelin proteins, including MAG,
MBP, oligodendrocyte-specific protein
(OSP/Claudin11), and PLP (Fig. 2F,G),
confirming that Klotho enhances OPC
maturation in vitro. Western blotting for
the cell proliferation marker, PCNA, re-
vealed no difference with Klotho treat-
ment (Fig. 2F,G), suggesting that Klotho
does not enhance OPC proliferation. We
also examined cell number and cell viabil-
ity by crystal violet staining and CellTiter-
Glo assay, which reflects the amount of
the ATP present, and we found no differ-
ence in Klotho-treated and untreated
OPCs from day 1 to day 4 in the cell via-
bility assay and for day 2 and day 4 for
crystal violet staining (Fig. 2H, I). Because
OPCs were allowed to attach and spread
for 3 d in the presence of basic FGF
(bFGF) and PDGF, cell proliferation oc-
curred during this period. After we treated
the OPCs with Klotho in culture medium
containing CNTF and T3, OPCs started to
differentiate but cell numbers remained constant as shown in
Figure 2H, I. We also observed no difference with a cell death
assay by measuring LDH release to the media with or without
Klotho. These results suggest that Klotho affects oligodendrocyte
differentiation and maturation, but not their proliferation and
cell death.
qRT-PCR analysis of Klotho effect on OPC maturation
Recently a transcriptome database for astrocytes, neurons, and
oligodendrocytes has been published providing cell type-specific
markers for these neural cells (Cahoy et al., 2008). To confirm the
effect of Klotho on OPC maturation, we performed qRT-PCR
analysis of the top 45 genes (see Table 4 for primers information)
from the OL maturation enriched gene list (Cahoy et al., 2008)
using RNA isolated from OPCs treated with Klotho or PBS only,
for 3 or 7 d. qRT-PCR revealed that, comparing 3 and 7 d differ-
entiated OPC, most of the genes were highly expressed at day 7
but had either low or undetectable expression at day 3 (Fig. 3A),
suggesting that the primer sets were working well to detect OPC
maturation-enriched genes. We then analyzed the gene expres-
sion changes of RNA from OPC treated with Klotho for 7 d
compared with PBS-treated control. We found that 37 of the 45
genes were detectable, and 78% (29 of 37) of the genes were
upregulated by Klotho. Of those 37, 21 genes reached significance
of p 0.05 (Fig. 3B). The qPCR results were consistent with the
results obtained from protein expression as assessed by Western
blot in that the expression of major myelin proteins was en-
hanced 2- to 3-fold in response to exogenous addition of Klotho
(Fig. 2F,G). These results demonstrate that Klotho can enhance
OPC maturation as shown by the immunostaining of the cells
with two separate oligodendrocyte markers O1 and CC-1, and by
Western blot analyses as shown in Figure 2B, D, F, G.
Effects of Klotho absence in vivo in Klotho knock-out mice
If Klotho is important for oligodendrocyte maturation in vitro,
Klotho knock-out mice should exhibit deficiencies in myelina-
tion. The ultrastructure of 35-day-old Klotho knock-out (/),
hemizygous (/) and control (/) mice brains was exam-
ined by electron microscopy. There was a significant reduction in
the percentage of myelinated fibers in both optic nerve and cor-
pus callosum, but not cervical spinal cord (Fig. 4), suggestive of
region-specific effects of Klotho expression. In the optic nerve,
Klotho/ mice exhibited a drastic reduction in the percentage
of myelinated fibers (10% compared with 90% in / litter-
mates) (Fig. 4E,F,M), whereas Klotho/ mice showed normal
numbers of myelinated fibers (Fig. 5C,D compared with Fig.
5A,B). In the corpus callosum, both Klotho/ and Klotho/
exhibited significantly impaired myelination (20% compared
with 90% in/mice) (Fig. 4G–M). No significant change was
seen in the percentage of myelinated fibers in the spinal cord (Fig.
4M). A similar reduction in the myelination of fibers in the cor-
pus callosum was found in two 25-d-old Klotho knock-out
brains, with only 16.4	 1.6% fibers being myelinated.
To decipher the potential basis for region-specific effects of
Klotho, we examined the distribution of Klotho in the corpus
callosum, spinal cord, and optic nerve from five 1.1-month-old
and five 1.6-month-old mice. The results showed that Klotho was
expressed in all three regions, with the highest expression in the
corpus callosum and lowest in spinal cord at the younger age (1.1
Figure3. qRT-PCR confirmationof theeffect of KlothoonOPCmaturation.A, RepresentativeqPCR results of differentiatedOPCs
for 3 and 7 d. The housekeeping geneGAPDHand the top two expressed genes,MBP andPlp1, are indicated.B, Fold change results
of the upregulated genes by qPCR analysis of RNA fromOPCs treatedwith Klotho for 7 d comparedwith control. OPCswere cultured
in medium containing bFGF and PDGF for 3 d, and then changed to the differentiation mediumwith CNTF and T3 with or without
Klotho for 7 d. *Statistical significance ( p 0.05, t test).
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months, Fig. 4N,O). The results of the Western blots of the three
specific brain samples represent the levels of available Klotho
protein surrounding these three brain regions. A higher Klotho
level (e.g., corpus callosum) implies that Klotho’s function is
needed in that region, and less Klotho suggests Klotho is less
necessary (e.g., spinal cord). These data, together with the elec-
tron microscopy results, suggest that Klotho is required for
proper myelination of fibers in the corpus callosum. We there-
fore examined the myelin markers MAG, MBP, and 2, 3cyclic
nucleotide-3-phosphodiesterase in brain tissues of 8-week-old
Klotho knock-out and control mice. Western blot analyses dem-
onstrated significant reduction of major myelin proteins in
Klotho-deficient mice compared with control mice (Fig. 4P,Q),
indicating that Klotho affects myelination via inducing myelin
protein production by oligodendrocytes.
To assess the effects of the hypomyelination seen in
Klotho/ mice on axonal microdomain organization, free-
floating sections were stained for caspr to label paranodes, and
-IV spectrin or NaV1.6 to label nodes. No differences were seen
in nodal staining patterns between -IV spectrin and NaV1.6
immunolabels. High-magnification confocal optical sections re-
veal that, within the corpus callosum, Klotho/ mice show a
significant decrease in paranodal length compared with wild-type
controls (Fig. 5). This decrease in paranodal length suggests that
there is less robust myelination in each axon in the Klotho/
mice consistent with hypomyelination seen in the ultrastructural
analysis. Although the absolute difference in paranodal length is
small (0.30 m), this average value would translate to one less
paranodal loop per axon (assuming each loop is 0.25 m)
(Trapp and Kidd, 2004). The decrease in paranodal length was
associated with a corresponding significant increase in nodal
length by 0.25 m (Fig. 5E). Analysis of nodal and paranodal
domains in the corpus callosum (Fig. 5F) and optic nerve (data
not shown) by electron microscopy did not demonstrate any
ultrastructural changes in axonal microdomains. Because nodal
length shortens during myelination (Dugandzija-Novakovic et
al., 1995; Vabnick et al., 1996), this increase in nodal length likely
represents more immature nodal segments in Klotho/ mice.
Longer nodes may be more energetically unstable and lead to
progressive axonal degeneration (Waxman, 1998).
Immunohistochemistry and quantitative analysis of brain
sections from Klotho knock-out mice at 5 weeks of age showed a
30% reduction in the numbers of Olig2 oligodendrocyte-
lineage cells in the fimbria compared with control mice (Fig.
6A–E). In the corpus callosum, we detected a similar trend to-
ward a significant reduction in Olig2 cells in Klotho knock-out
mice (data not shown). In addition, we found a similar and con-
firmatory reduction (21%) in the number of mature oligoden-
drocytes immunopositive for the GST-Pi marker (Mason et al.,
2004), suggestive of reduced levels of GST-Pi-positive mature
oligodendrocytes in the fimbria of Klotho-null mice compared
with control mice (Fig. 6F–J).
To determine whether these changes in the expression of my-
elin proteins are also seen at the mRNA level, we performed mi-
croarray analysis using RNA from 8-week-old Klotho/ and
Klotho/ mice brain tissue, and applied gene set
enrichment analysis to identify which canonical pathways were
involved. With this approach, we found that a set of myelin-
related genes were downregulated. To examine whether Klotho
affects gene expression of these myelin-related genes, we per-
Figure 4. Klotho knock-out mice exhibit impaired myelination. A–L, The 4.5-week-old Klotho/, Klotho/, or Klotho/mice were processed for electron microscopy. Cross-sectional
images showexamples ofmyelination patterns for optic nerve (A-F ) at 2900 (A,C,E) and 5800 (B,D,F ) and corpus callosum (G–L) at 2900 (G, I,K ) and 5800 (H, J, L). Scale bars:E, 2m;
F, 500 nm. As, Astrocyte.M, The number of myelinated and unmyelinated axons were counted and graphed as percentage of myelinated fibers. Averages represent axonal counts analyzed from 3
to 6 different images. *Statistical significance ( p 0.0001, t test). Error bars indicate SD. ON, Optic nerve; CC, corpus callosum; SC, spinal cord.N, Klotho expression in CC, SC, and ON.Western blot
analysis of Klotho from the lysates of 1.1- and 1.6-month-old control mice CC, SC, and ON tissues. O, Statistical analysis of Klotho expression in N with GAPDH as loading control. *Statistical
significance ( p 0.05, t test). Error bars indicate SD. Sample size is n 4 for each age. P, Major myelin proteins were largely reduced in Klotho knock-out mice. Western blot analysis of myelin
markers from the brain lysates of 8-week-old Klotho knock-out (KL/) and control (KL/)mice.Q, Statistical analysis of themyelinmarkers inPwith tubulin as control. *Statistical significance
( p 0.05, t test). Error bars indicate SD.
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formed qRT-PCR analysis of the 15
myelin-related genes. The qRT-PCR re-
sults revealed that all of the myelin-related
genes tested were reduced compared with
control mice, and 11 of 15 genes were
downregulated2-fold (Table 1). The re-
sults demonstrate that lack of Klotho re-
sulted in reduction in expression of major
myelin genes.
To identify potential transcription fac-
tors involved in Klotho-mediated re-
sponses in OPCs, we examined regulatory
effects of Klotho using a signaling path-
way luciferase reporter system. We opti-
mized transfection efficiency in primary
oligodendrocytic cells by testing 15 avail-
able transfection reagents and found that
Lipofectamine 2000 (Invitrogen) was su-
perior for the luciferase reporter system in
these cells (data not shown). We then
tested 45 signaling pathway reporters
(QIAGEN; Table 2) in OPCs with or with-
out Klotho treatment. In addition, we also
tested the Pax3 reporter because Pax3 re-
pression is directly relevant to oligoden-
drocyte maturation to a myelinating
phenotype (He et al., 2007). The results
showed that Klotho inhibited C/EBP,
AP1, NFB, and Pax3 activities, whereas it
enhanced liver X receptor (LXR), antiox-
idant response element, STAT3, proges-
terone receptor, and SRE MAPK/ERK
transcription factor activities (Fig. 7B; Ta-
ble 3). The effect of Klotho on STAT3
phosphorylation in OPCs was also con-
firmed by Western blot (Fig. 7A). These
results revealed the possible transcription
factors involvement in Klotho-mediated
responses in OPCs (Table 4).
Discussion
Klotho affects oligodendrocyte
maturation and myelination
In prior work, our group discovered re-
ductions in Klotho in the aging brain
white matter (Duce et al., 2008), where
myelin deficits are also observed (Hinman
and Abraham, 2007), suggesting a con-
nection between Klotho expression and
myelination. Thus, in this manuscript, we
focused on the effect of Klotho on oligodendrocytes, the myeli-
nating cells of the CNS. Our findings indicate a dramatic and
important effect of Klotho on oligodendrocyte maturation and
on myelination. Klotho enhances expression of MBP, MAG, PLP,
and OSP/claudin11, all being major myelin proteins, and induces
OPC maturation in vitro. In vivo, Klotho knock-out mice have
severe hypomyelination of the optic nerve and corpus callosum,
which alters axonal microdomain organization. Myelin defects
associated with loss of Klotho expression strongly indicate that
decreased Klotho expression could result in slowed action poten-
tial propagation, conduction block, and destabilized coordinated
neuronal communication, as seen in hypomyelinating and demy-
elinating diseases (Hinman and Abraham, 2007; Hanafy and
Sloane, 2011). The numbers of myelinated fibers in the optic
nerves and corpus callosum of the Klotho knock-out mice were
much lower that in the wild-type mice, as determined by electron
microscopy studies (Fig. 4). However, the numbers of mature
and total oligodendrocytes in the fimbria were reduced by a lower
percentage (Fig. 6). These data suggest that those oligodendro-
cytes that appear mature, as judged by their staining with GST-Pi,
were not able to myelinate axons properly, indicating an impor-
tant role of Klotho in the myelination process.
Figure 5. Axonal microdomains are altered in Klotho/mice. Five sections each of corpus callosum from twowild-type and
two homozygous Klotho/ mice were stained for caspr (green) and -IV spectrin (red). A, C, Wild-type mice have normal
compact paranodal and nodal structure. B, D, Klotho/ mice show an abundance of shorter paranodal segments and longer
nodal segments (arrows). E, Measurements of nodal and paranodal length show a statistically significant decrease in paranodal
length in Klotho/mice associatedwith a significant increase in nodal length. *Statistical significance ( p 0.001, t test). Scale
bar, 2m. F, Electron microscopic longitudinal section analysis of nodes of Ranvier in corpus callosum from wild-type (KL/)
and Klotho/ (KL/) mice at 13,000. Arrows indicate the junction between node and paranode. N, Node; P: paranode.
Scale bars, 500 nm.
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Klotho-activated signaling pathways include Akt and ERK1/2
We found that Akt and ERK1/2 signaling likely regulates OPC
cells subjected to Klotho treatment. This finding is consistent
with the data reported by Wolf et al. (2008) who found that
both pathways were involved in Klotho-treated HEK293 and
breast cancer cells. Moreover, a recent study reported that
Klotho induced ERK/MEK phosphorylation in HUVEC cells
(Maekawa et al., 2011). Our results also suggest that Klotho
could act on an as-yet unidentified Klotho receptor expressed
on oligodendrocytes.
Oligodendrocyte development is regulated by numerous
growth factors, which can signal through Akt- and ERK1/2-
dependent pathways (Bhat and Zhang, 1996; Baron et al., 2000;
Bansal et al., 2003; Fortin et al., 2005; Du et al., 2006; Cui and
Almazan, 2007; Frederick et al., 2007; Bibollet-Bahena et al.,
2009; Frost et al., 2009; Younes-Rapozo et al., 2009; Van’t Veer et
al., 2009; Fyffe-Maricich et al., 2011; Guardiola-Diaz et al., 2012).
Klotho has been reported to regulate insulin/IGF-1, FGF23, and
Wnt signaling (Kuro-o, 2006, 2008a). In OPCs, Klotho is unlikely
to function through IGF-1 signaling because Klotho inhibits the
insulin/IGF-1 signaling pathway (Kurosu et al., 2005) and IGF-1
was reported to enhance OPC maturation and myelination
(Bibollet-Bahena and Almazan, 2009). It is unknown whether
FGF23, for which Klotho serves as a coreceptor in the kidney, has
a role in neurodevelopment. However, our findings show that
Klotho treatment of OPCs induces the phosphorylation of FRS2,
a positive regulator of FGF signaling upstream of Akt and Erk
pathway, which is phosphorylated in oligodendrocytes upon ac-
tivation of the FGF receptor (Bryant et al., 2009). Another puta-
tive receptor on OPCs is the NGF receptor TrkA because FRS2 is
Figure 6. Immunohistochemistry and quantitative analysis of expression of Olig2 and GST-Pi in brain sections from 5-week-old Klotho/ and Klotho/ mice. A–D, IHC images show
examples of Olig2 nuclear staining patterns at 4 (A, B) and 20 (C, D). Scale bars: A, B, 200m; C, D, 50m. A, C, KL/. B, D, KL/. The fimbria region is outlined. Hb, Habenula. E, Cell
counting of Olig2was performed as described inMaterials andMethods. The number of Olig2 cells in fimbriawere counted and the percentage of Olig2 cells in KL/ and KL/ graphed.
*Statistical significance ( p 0.01, t test). Error bars indicate SD. F–I, IHC of brain sections with antibodies to the mature oligodendrocyte marker GST-Pi at 4 (F, G) and 20 (H, I ). Scale bars:
F, G, 200m;H, I, 50m. J, Quantitation of GST-Pi cells as described in Materials and Methods. The GST-Pi cells in fimbria were counted and the percentage of GST-Pi cells in KL/ and
KL/ graphed. *Statistical significance ( p 0.05, t test). Error bars indicate SD.
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able to bind directly to both FGF and NGF
receptors (Meakin et al., 1999; Ong et al.,
2000). Possibly, Klotho functions through
the FGF signaling pathway indirectly via
another FGF ligand, or Klotho could
modulate signaling of other cytokines in
astrocytes via FGF signaling, as has been
shown for insulin/IGF-1 signaling in Cae-
norhabditis elegans (Chateau et al., 2010).
We cannot rule out the possibility that
Klotho sequesters a ligand and blocks its
accessibility to the receptor, or that
Klotho binds directly to a receptor to pre-
vent a ligand–receptor interaction. An-
other reported mechanism for Klotho
effects is via the inhibition of the Wnt/-
catenin pathway, where Klotho may func-
tion as a secreted Wnt antagonist (Liu et
al., 2007). Activating the Wnt/-catenin
pathway delays the development of myeli-
nating oligodendrocytes (Fancy et al.,
2009; Feigenson et al., 2009), whereas
Olig2-induced neuronal stem cell differ-
entiation into mature oligodendrocytes
involves downregulation of the Wnt sig-
naling pathway (Ahn et al., 2008).
Whether Klotho stimulates oligodendro-
cyte maturation through the Wnt or insu-
lin/IGF signaling pathways in addition to the FGF and NGF
pathways is currently under investigation. It is interesting to note
that, in vivo, FGFR1/2 and ERK1/2 MAPK signaling in oligoden-
drocytes has recently been shown to regulate the growth of the
myelin sheath, independent of oligodendrocyte differentiation
(Furusho et al., 2012; Ishii et al., 2012).
Potential transcription factors involved in Klotho-
mediated responses
We identified a set of transcription factors potentially involved in
Klotho-dependent effects on OPC cells using the luciferase re-
porter system. Several of the transcription factors have been re-
ported previously to be associated with Klotho functions,
including C/EBP, AP1/JNK, NFB, STAT3, and SRE MAPK/ERK
(Yamamoto et al., 2005; Chihara et al., 2006; Medici et al., 2008;
Wolf et al., 2008; Hsieh et al., 2010; Thurston et al., 2010; Liu et
al., 2011; Zhao et al., 2011). Klotho protein increases resistance to
oxidative stress at the cellular and organismal level in mammals
(Nagai et al., 2003; Kurosu et al., 2005; Rakugi et al., 2007; Shih
and Yen, 2007). Klotho-deficient mice have impaired cognitive
function compared with wild-type mice, and treatment with the
antioxidant -tocopherol improves cognition (Nagai et al.,
2003), suggesting that Klotho may function as a neuroprotective
factor. In addition, Klotho protein showed a neuroprotective ef-
fect on human neural stem cells (Foster et al., 2011), likely
through the antioxidative stress effect of Klotho. We found an
increase in the antioxidant response element activity, which in-
dicates that the antioxidative function of Klotho may be involved
in the protection of oligodendrocytes. The new transcription fac-
tor activities identified to be associated with Klotho include Pax3,
LXR, and the progesterone receptor. LXRs are oxysterol and nu-
clear receptors, which play an important role in the control of
cholesterol homeostasis (Repa and Mangelsdorf, 2000; Whitney
et al., 2002).
Implications of Klotho induced transcription factor changes
for oligodendrocyte biology
The lack of LXRs in mice leads to disorganized myelin sheaths,
suggesting a role for the LXRs in myelination (Wang et al., 2002).
Pax3 is important for development of myelinating glia and the
myelination process (Wegner, 2000). An inverse correlation was
observed between expression of Pax3 and MBP, suggesting that it
represses MBP transcription (Kioussi et al., 1995). We found that
Klotho inhibited Pax3 reporter activity and increased MBP ex-
pression in OPCs; therefore, we speculate that Klotho may in-
crease MBP through the Pax3 pathway. Further investigation is
required to decipher the direct or indirect involvement of the
Pax3 transcription factor pathway resulting in Klotho’s effects on
oligodendrocytes. The transcription factor STAT3 has been pre-
viously reported to be involved in oligodendrocyte differentia-
tion (Dell’Albani et al., 1998; Massa et al., 2000). Klotho
treatment induced STAT3 phosphorylation, which is required
for STAT3 activity (Bromberg and Darnell, 2000). Furthermore,
the protein tyrosine phosphatase SHP-1 regulates oligodendro-
cyte differentiation through STAT3 in response to the IL-6 family
of cytokines (Massa et al., 2000). Thus, Klotho may also act
through STAT3 to drive OPC maturation.
Regardless of which receptor, signaling pathway(s), and tran-
scription factors are involved, our in vitro and in vivo studies
indicate that Klotho clearly has a significant regulatory role in
OPC maturation and developmental myelination. Interestingly,
Klotho has been reported to have a role in cell differentiation of
diverse systems throughout the body, including bone, fat, and the
cardiovascular system (Kawaguchi et al., 1999; Shimada et al.,
2004; Chihara et al., 2006). Klotho gene expression appears to
cause the impairment of both osteoblast and osteoclast differen-
tiation (Kawaguchi et al., 1999). In addition, both angiogenesis
and vasculogenesis are impaired in Klotho mutant mice, suggest-
ing a role for Klotho in differentiation of endothelial precursor
cells (Shimada et al., 2004). As a humoral factor, Klotho works to
Figure 7. Transcription factors involved in Klotho regulation of OPCs. A, Western blot analysis of STAT3 phosphorylation upon
Klotho treatment of OPC cells. B, Luciferase assay of luciferase reporters in OPC cells. OPCs were transfected with the reporter
plasmids with Renilla luciferase and treatedwith or without Klotho for 24 h followed by luciferase assay. The fold change compar-
ing Klotho treated to control is shown. p values indicate statistical significance by t test.
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promote expression of differentiation markers in 3T3-L1 cells,
indicating that Klotho may play an essential role in adipocyte
differentiation (Chihara et al., 2006).
In conclusion, we demonstrate a novel function of Klotho in
oligodendrocyte maturation and developmental myelination of
the CNS. This role is in addition to Klotho’s function as a neuro-
protective factor through preventing neurons from oxidative
damage as proposed previously (Kuro-o, 2008b). Klotho may
function as a humoral factor secreted by neurons or choroid
plexus to promote myelination in neurodevelopment. It is possi-
ble that Klotho plays a regulatory role in maintaining or support-
ing oligodendrocyte and OPC function in the adult CNS, once
the development has plateaued. Because we observed downregu-
lation of Klotho in aged brain white matter, it is plausible that
reduced Klotho level may account for damage to myelin and
age-associated cognitive decline, and increasing Klotho level may
protect myelin integrity and prevent myelin degeneration in the
aged brain. Klotho is thus a new member of the large family of
proteins that are crucial to neuron-oligodendrocyte communica-
tion, and studies on the functions of Klotho are likely to provide
new therapeutic approaches for diseases in which myelin abnor-
malities play important pathogenic roles, such as multiple scle-
rosis and schizophrenia (Edgar et al., 2004; Taveggia et al., 2010).
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